The Power of Two. The Ease of One.
Delivering What Matters, Together.
Strategic Alliance for Drug Substance and Drug Product ADC Manufacturing
With the development and clinical use of antibody-drug conjugates (ADCs) currently gaining significant momentum, the demand for contract development and manufacturing services continues to increase. In response, we have forged a strategic alliance with Simtra BioPharma Solutions to streamline and accelerate the delivery of these targeted therapies and other bioconjugates to patients.
As two industry-leading contract development and manufacturing organizations (CDMOs) in the ADC field, we are united by a shared goal of delivering your drug development program to market more efficiently.
We are bringing together the extensive experience and expertise of each company to meet our clients' unique needs, from early clinical development to commercial production. Our dedicated teams help to navigate the complexities of your drug development program with confidence.
Two Experts, One Streamlined Solution
Our streamlined approach encompasses every stage, including bioconjugation, linker and payload supplies, formulation development, and final fill-finish of drug substance, enabling us to meet the unique demands of each project.
Customers will receive coordinated support with designated project managers at each of the partners’ sites working closely together to ensure smooth transfers and expedite timelines.
Simplified supply chain and reduced complexities
Shortening timelines and harmonizing processes
Operational synergies
About our ADC & Bioconjugation CDMO Services
With more than 15 years of experience as a US-based conjugation and linker-payload CDMO within a global network, we have a proven track record of supporting clinical programs from IND to PPQ for commercialization. Our vast expertise in the conjugation of drug linkers to monoclonal antibodies (mAbs) encompasses various conjugation chemistries and linker-payload technologies. Our facilities are specialized for handling highly potent compounds, and we are actively expanding our capacity to prepare for future growth.
About Simtra BioPharma Solutions
With more than 65 years of sterile injectable manufacturing experience, Simtra BioPharma Solutions offers world-class GMP sterile fill and finish services, deep scientific and technical expertise, and a uniquely collaborative approach to support our customers’ strategic objectives.
Our teams of quality-driven, long-tenured experts deliver tailored clinical or commercial manufacturing solutions to help our biotech and pharmaceutical customers meet the needs of patients around the world.
To continue reading please sign in or create an account.
Don't Have An Account?